The Hidden Agenda Of Attention Deficit Hyperactivity Disorder Drugs Market Industry.
![]() |
Attention Deficit Hyperactivity Disorder Drugs Market |
The global attention
deficit hyperactivity disorder drugs market is expected to grow at a CAGR
of 5.59% during the forecast period. Based on the product, the market has been
segmented into stimulants and non-stimulants. As per the latest market research report published by
Technavio, the global attention deficit hyperactivity disorder drugs market
size will grow at a CAGR of almost 6% during 2018-2023, and the market size
will increase by USD 5.29 billion during 2019-2023. Get the free sample report
below for the detailed information.
Stimulants are considered as the first-line therapy
for the treatment of ADHD. Hypothetically it seems contradictory to treat ADHD
symptoms with CNS stimulant or psychostimulant, it works by increasing
neurotransmitter levels in the brain, namely dopamine and norepinephrine, which
play an important role in improving brain functions. The therapeutic efficacy
for the treatment of ADHD has been established for over 50 years, and they are
the most popular prescribed medication for the treatment.
Stimulants are approved by the US FDA for use in
children and adults and are considered as gold standards for the treatment of
ADHD. As per the NIH, in 2008, approximately 2.8 million children with ADHD
were reported to be receiving psychostimulants for their treatment.
Additionally, there are more than 250 controlled studies that have demonstrated
the therapeutic efficacy of stimulants for the treatment of ADHD. Considering
the vast use of stimulants in the ADHD therapeutic area, the attention
deficit hyperactivity disorder drugs market
is expected to witness rapid growth during the forecast period. To know the complete and in-depth analysis and
forecast of this market get the complete report by clicking the link below.
Get the Complete Report @ http://bit.ly/2qfA2jh
Comments
Post a Comment